The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative.
about
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDSMegestrol acetate for treatment of anorexia-cachexia syndromeMegestrol acetate for treatment of anorexia-cachexia syndromeThe therapeutic potential of cannabis and cannabinoidsCannabinoids in health and diseaseAdverse effects of medical cannabinoids: a systematic reviewThe endocannabinoid system as an emerging target of pharmacotherapyClinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDSHigh prevalence of adrenal suppression during acute illness in hospitalized patients receiving megestrol acetateSafety of megestrol acetate in palliating anorexia-cachexia syndrome in patients with castration-resistant prostate cancer.Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspensionPatterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada.Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis.Pharmacologic management of human immunodeficiency virus wasting syndrome.Dronabinol and chronic pain: importance of mechanistic considerations.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.Progesterone therapy for the treatment of non-cancer cachexia: a systematic review.[Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].Quantitative Assessment of Food Effect on the Pharmacokinetics of Nano-Crystallized Megestrol Acetate.Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice.Increased body weight and improved quality of life in AIDS patients following V-1 Immunitor administration.LC-MS/MS method for determination of megestrol in human plasma and its application in bioequivalence study.Systematic review and meta-analysis of cannabinoids in palliative medicine.Pharmacokinetics of a combination of Δ9-tetrahydro-cannabinol and celecoxib in a porcine model of hemorrhagic shock.Megestrol acetate for cachexia-anorexia syndrome. A systematic review.
P2860
Q24197970-FDA64BA5-2E18-4870-B0C0-38D1398522E5Q24198954-7DB79B22-548B-4768-98C3-1E8CD8C3E596Q24244142-9F9C6E34-A641-410C-A2E0-DEFB780208F6Q24600806-E2E0B26E-E968-4DE1-B58C-897B9432DB64Q24633884-DB48F283-67C3-4926-8604-77669330CC6BQ24644380-153133B5-A4D7-467C-9AE6-B41F32CFA5DDQ24648473-80A9808E-4DC4-4730-ACAD-09159B1474BBQ26765257-2902A152-4148-4F50-BF04-2F55B893F493Q28306821-1213AF78-D2D3-4305-A194-B90995C95688Q36841080-4D3199E7-A692-48E3-82FC-9614D41F9238Q37354474-0A4D1EBD-2E58-43C7-9E52-B41BB7B85D72Q37632413-FB0E40F3-1D8D-4269-8792-D45808067DC6Q37919370-CB3F60FD-8C2E-472A-B30F-E5A4F048AF8BQ38208278-5118AB5D-A3AA-43CB-936C-1E095DB3643CQ38211191-1E2E2F2C-F56F-43A1-B567-ED97E80E5E35Q38503842-7D88E2E3-109A-4602-9A09-5BDD0A21CB8BQ38736405-40B697C5-863D-45C8-892E-718B6EB4D645Q38813419-F1F5269C-AF4C-4A72-A4BC-74AD6415C99EQ39177603-30258FDD-44DD-4E85-9AB0-4956408737C1Q39379170-C57AE5B3-8940-4F4C-B357-D915E10DA0A5Q41428934-AE2C9B3D-216F-49FF-9AAD-D145DE60D2DAQ42615663-D9827F04-6709-4E40-920F-7CB3456FD915Q46782529-D206A946-E5D8-4A01-8B73-D799FC296D20Q50201189-2DACC6FE-53F6-47F7-A8BD-B45C6A63BCE7Q51600580-4C3D76CF-0315-43B6-A849-994C15466A41Q52654667-8B6BD49E-4557-4A05-9DB9-A54FA6BD836F
P2860
The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
The safety and pharmacokinetic ...... Treatment Research Initiative.
@en
The safety and pharmacokinetic ...... Treatment Research Initiative.
@nl
type
label
The safety and pharmacokinetic ...... Treatment Research Initiative.
@en
The safety and pharmacokinetic ...... Treatment Research Initiative.
@nl
prefLabel
The safety and pharmacokinetic ...... Treatment Research Initiative.
@en
The safety and pharmacokinetic ...... Treatment Research Initiative.
@nl
P2093
P356
P1476
The safety and pharmacokinetic ...... Treatment Research Initiative.
@en
P2093
Timpone JG
P304
P356
10.1089/AID.1997.13.305
P577
1997-03-01T00:00:00Z